论文部分内容阅读
据《Annais of Internal Medieine》1997年126卷第9期报道 用ursodiol或秋水仙碱治疗原发性胆汁性肝硬变可以稳定病情或减缓病情发展的速度,但尚未见有关于自行或药物治疗后减轻的文献报道。为了验证原发性胆汁性肝硬变是否对低剂量口服甲氨喋呤治疗有完全的反应,美国Kaplan等教授在科学院医疗中心进行一项前瞻性病例研究,该研究至少观察6年。19名经活检证实肝硬变前期的原发性胆汁性肝硬变患者,5人生病至少1年,其
According to the “Annais of Internal Medieine” Volume 126, Volume 9, 1997 reported using ursodiol or colchicine in the treatment of primary biliary cirrhosis can stabilize the condition or slow the progression of the disease, but has not been seen on their own or after drug treatment Reduce the literature. In order to verify whether primary biliary cirrhosis is completely responsive to low-dose oral methotrexate treatment, Kaplan et al. Conducted a prospective case-study at the Medical Center of the Academy of Sciences, at least for 6 years. Nineteen patients with primary biliary cirrhosis confirmed by biopsy prior to cirrhosis were 5 sick for at least 1 year,